NMTC insider transaction filings
NEUROONE MEDICAL TECHNOLOGIES Corp — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-02. Screen NMTC transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-02 | 4 | Christianson Mark — Market Development Director | Sale (S): 10,000 @ $3.18 | EDGAR |
| 2026-04-07 | 4 | Mills Jason Richard — Director | Grant/award (A): 41,929 @ $0 · Grant/award (A): 26,036 (derivative) @ $0 | EDGAR |
| 2026-04-07 | 4 | Andrle Edward — Director | Grant/award (A): 41,929 @ $0 · Grant/award (A): 26,036 (derivative) @ $0 | EDGAR |
| 2026-04-07 | 4 | MATHIESEN JEFFREY S — Director | Grant/award (A): 41,929 @ $0 · Grant/award (A): 26,036 (derivative) @ $0 | EDGAR |
| 2026-04-07 | 4 | BUCKMAN PAUL — Director | Grant/award (A): 41,929 @ $0 · Grant/award (A): 26,036 (derivative) @ $0 | EDGAR |
| 2026-04-01 | 4 | Mertens Steve — Chief Technology Officer | Tax withholding (F): 906 @ $0.78 | EDGAR |
| 2026-04-01 | 4 | Christianson Mark — Business Development Director | Sale (S): 15,363 @ $0.74 · Tax withholding (F): 253 @ $0.78 | EDGAR |
| 2026-04-01 | 4 | Rosa David A — CEO and President, Director | Tax withholding (F): 2,458 @ $0.78 | EDGAR |
| 2026-03-16 | 4 | Christianson Mark — Business Development Director | Sale (S): 817 @ $0.80 · Sale (S): 100 @ $0.80 | EDGAR |
| 2026-03-12 | 4 | Christianson Mark — Business Development Director | Sale (S): 11,611 @ $0.80 · Sale (S): 2,109 @ $0.80 | EDGAR |
| 2026-03-03 | 4 | Wambeke David J. — Chief Business Officer | Purchase (P): 1,000,000 @ $0.67 · Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2026-02-20 | 4 | Mertens Steve — Chief Technology Officer | Tax withholding (F): 7,376 @ $0.68 | EDGAR |
| 2026-02-20 | 4 | Christianson Mark — Business Development Director | Tax withholding (F): 1,812 @ $0.68 | EDGAR |
| 2026-02-20 | 4 | Rosa David A — CEO and President, Director | Tax withholding (F): 71,325 @ $0.68 | EDGAR |
| 2026-01-05 | 4 | Mertens Steve — Chief Technology Officer | Tax withholding (F): 906 @ $0.76 | EDGAR |
| 2026-01-05 | 4 | Christianson Mark — Business Development Director | Tax withholding (F): 253 @ $0.76 | EDGAR |
| 2026-01-05 | 4 | Rosa David A — CEO and President, Director | Tax withholding (F): 2,458 @ $0.76 | EDGAR |
| 2026-01-02 | 4 | Mills Jason Richard — Director | Grant/award (A): 7,758 @ $0 · Grant/award (A): 4,806 (derivative) @ $0 | EDGAR |
| 2025-10-01 | 4 | Mertens Steve — Chief Technology Officer | Tax withholding (F): 906 @ $0.89 | EDGAR |
| 2025-10-01 | 4 | Christianson Mark — Business Development Director | Tax withholding (F): 253 @ $0.89 | EDGAR |
| 2025-10-01 | 4 | Rosa David A — CEO and President, Director | Tax withholding (F): 2,458 @ $0.89 | EDGAR |
| 2025-09-09 | 4 | Christianson Mark — Business Development Director | Sale (S): 30,000 @ $0.74 | EDGAR |
| 2025-07-02 | 4 | Christianson Mark — Business Development Director | Tax withholding (F): 253 @ $0.68 | EDGAR |
| 2025-07-02 | 4 | Mertens Steve — Chief Technology Officer | Tax withholding (F): 906 @ $0.68 | EDGAR |
| 2025-07-02 | 4 | Rosa David A — CEO and President, Director | Tax withholding (F): 2,458 @ $0.68 | EDGAR |
| 2025-06-25 | 4 | Andrle Edward — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-06-25 | 4 | MATHIESEN JEFFREY S — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-06-25 | 4 | BUCKMAN PAUL — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Christianson Mark — Business Development Director | Sale (S): 10,000 @ $0.58 | EDGAR |
| 2025-06-03 | 4 | Johns Emily J. — General Counsel | Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2025-05-23 | 4 | Christianson Mark — Business Development Director | Sale (S): 14 @ $0.65 · Sale (S): 8,967 @ $0.62 | EDGAR |
| 2025-05-21 | 4 | Christianson Mark — Business Development Director | Sale (S): 8,006 @ $0.67 · Sale (S): 3,013 @ $0.66 | EDGAR |
| 2025-04-21 | 4 | Volker Christopher — Chief Operating Officer | Grant/award (A): 575,000 (derivative) @ $0 | EDGAR |
| 2025-04-21 | 4 | McClurg Ronald W. — Chief Financial Officer | Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2025-04-21 | 4 | Mertens Steve — Chief Technology Officer | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2025-04-21 | 4 | Christianson Mark — Business Development Director | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2025-04-21 | 4 | Rosa David A — CEO and President, Director | Grant/award (A): 750,000 (derivative) @ $0 | EDGAR |
| 2025-04-07 | 4 | McClurg Ronald W. — Chief Financial Officer | Purchase (P): 200,000 @ $0.50 | EDGAR |
| 2025-04-07 | 4 | Rosa David A — CEO and President, Director | Purchase (P): 100,000 @ $0.50 | EDGAR |
| 2025-04-02 | 4 | Mertens Steve — Chief Technology Officer | Tax withholding (F): 906 @ $0.85 | EDGAR |
| 2025-04-02 | 4 | Christianson Mark — Business Development Director | Tax withholding (F): 253 @ $0.85 | EDGAR |
| 2025-04-02 | 4 | Rosa David A — CEO and President, Director | Tax withholding (F): 2,458 @ $0.85 | EDGAR |
| 2025-02-20 | 4 | Mertens Steve — Chief Technology Officer | Tax withholding (F): 7,376 @ $1.16 | EDGAR |
| 2025-02-20 | 4 | Christianson Mark — Business Development Director | Tax withholding (F): 1,812 @ $1.16 | EDGAR |
| 2025-02-20 | 4 | Rosa David A — CEO and President, Director | Tax withholding (F): 71,325 @ $1.16 | EDGAR |
| 2025-02-19 | 4 | Andrle Edward — Director | Grant/award (A): 27,778 @ $0 · Grant/award (A): 17,025 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | MATHIESEN JEFFREY S — Director | Grant/award (A): 27,778 @ $0 · Grant/award (A): 17,025 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | BUCKMAN PAUL — Director | Grant/award (A): 27,778 @ $0 · Grant/award (A): 17,025 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4 | Mertens Steve — Chief Technology Officer | Tax withholding (F): 252 @ $1.15 | EDGAR |
| 2025-02-04 | 4 | Christianson Mark — Business Development Director | Tax withholding (F): 90 @ $1.15 | EDGAR |
Recent 8-K events — NEUROONE MEDICAL TECHNOLOGIES Corp
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-12 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-22 | 8-K | 4.02 — Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-04 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-04-30 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-14 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-03 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-25 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-02-17 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=NMTC returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →